DanaherDHR
DHR
0
Funds holding %
of 7,390 funds
0
Analysts bullish %
of 7 analysts
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
76% more call options, than puts
Call options by funds: $1.78B | Put options by funds: $1.01B
24% more first-time investments, than exits
New positions opened: 245 | Existing positions closed: 197
0.75% more ownership
Funds ownership: 78.42% [Q3] → 79.17% (+0.75%) [Q4]
0% more funds holding
Funds holding: 2,239 [Q3] → 2,249 (+10) [Q4]
17% less capital invested
Capital invested by funds: $159B [Q3] → $133B (-$26.4B) [Q4]
18% less repeat investments, than reductions
Existing positions increased: 762 | Existing positions reduced: 932
42% less funds holding in top 10
Funds holding in top 10: 97 [Q3] → 56 (-41) [Q4]
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$240
17%
upside
Avg. target
$257
25%
upside
High target
$277
35%
upside
7 analyst ratings
5 positive
71%
2 neutral
29%
0 negative
0%
Stifel Daniel Arias 20% 1-year accuracy 4 / 20 met price target | 26%upside $260 | Buy Upgraded | 14 Mar 2025 |
Citigroup Patrick Donnelly 23% 1-year accuracy 7 / 31 met price target | 29%upside $265 | Buy Maintained | 30 Jan 2025 |
RBC Capital Conor McNamara 5% 1-year accuracy 2 / 37 met price target | 35%upside $277 | Outperform Reiterated | 30 Jan 2025 |
Baird Catherine Schulte 0% 1-year accuracy 0 / 20 met price target | 25%upside $258 | Outperform Maintained | 30 Jan 2025 |
Wells Fargo Brandon Couillard 14% 1-year accuracy 3 / 21 met price target | 17%upside $240 | Equal-Weight Maintained | 30 Jan 2025 |
Financial journalist opinion
Based on 6 articles about DHR published over the past 30 days
Positive
Seeking Alpha
6 days ago
8 Upcoming Dividend Increases, Including A King
Highlighting eight companies with upcoming dividend increases, four exceeding 10%, and an average increase of 11.4%, median at 9%. My investment strategy focuses on buying, holding, and expanding stakes in companies with consistent dividend growth and benchmark-beating performance. The list is curated using data from the "U.S. Dividend Champions" spreadsheet and NASDAQ, ensuring a minimum of five years of dividend growth.
Positive
Seeking Alpha
1 week ago
Danaher: Near 5-Year Low Is A Great Entry Point
Danaher Corporation is trading near its 5-year low, presenting a potential buying opportunity for growth investors despite near-term headwinds. DHR's strong fundamentals include leadership in biotechnology, life sciences, and diagnostics, with robust profitability and free cash flow. Growth catalysts include advancements in bioprocessing, molecular diagnostics, and neurodegenerative disease detection, with expected EPS growth of 10%-13% annually over the next three years.
Neutral
PRNewsWire
1 week ago
Danaher Schedules First Quarter 2025 Earnings Conference Call
WASHINGTON , March 20, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2025 on Tuesday, April 22, 2025 beginning at 8:00 a.m. ET and lasting approximately one hour.
Negative
Zacks Investment Research
2 weeks ago
Here's Why You Should Avoid Betting on Danaher Stock Right Now
Persistent softness in the Life Sciences segment weighs on DHR's performance. An increase in operating expenses is an added concern.
Neutral
PRNewsWire
2 weeks ago
Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System
The new DxC 500i Analyzer Offers Flexibility and Scalability with Broad Chemistry and Immunoassay Assay Menu BREA, Calif. , March 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) clearance from the U.S. Food and Drug Administration.
Neutral
Seeking Alpha
3 weeks ago
Danaher Corporation (DHR) TD Cowen 45th Annual Health Care Conference Transcript
Danaher Corporation (NYSE:DHR ) TD Cowen 45th Annual Health Care Conference Call March 5, 2025 10:30 AM ET Company Participants Rainer Blair – President and Chief Executive Officer Conference Call Participants Dan Brennan – TD Cowen Dan Brennan Welcome to day-three of the TD Cowen Global Healthcare Conference. I'm Dan Brennan, I follow tools and diagnostics.
Neutral
PRNewsWire
1 month ago
Danaher to Present at TD Cowen Health Care Conference
WASHINGTON , Feb. 25, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Wednesday, March 5, 2025 at 10:30 a.m.
Positive
Zacks Investment Research
1 month ago
Danaher Rewards Shareholders With 18.5% Dividend Increase
DHR's measures to consistently reward shareholders through dividends and share buybacks hold promise.
Neutral
GlobeNewsWire
1 month ago
Industrial Laser Marking Machine Market To Reach USD 6.41 Billion by 2032, Growing at CAGR 8.1% | Coherent, Inc., Danaher Corporation, Epilog Laser
An industrial laser marking machine uses laser technology to engrave, etch, or mark materials with precision for identification, branding, or tracking. An industrial laser marking machine uses laser technology to engrave, etch, or mark materials with precision for identification, branding, or tracking.
Positive
MarketBeat
1 month ago
3 Stocks Offering Strong Value and Stability
Though not as safe a bet as safe-haven assets like precious metals, value stocks are nonetheless an enticing option for investors when the market gets bumpy. An undervalued company that has excellent fundamentals but a less-than-stellar recent stock performance history is often better positioned to benefit during periods of volatility than growth names with less of a track record of success.
Charts implemented using Lightweight Charts™